4.5 Review

DNMT1: catalytic and non-catalytic roles in different biological processes

Journal

EPIGENOMICS
Volume 14, Issue 10, Pages 629-643

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/epi-2022-0035

Keywords

cancer; cell proliferation; cellular plasticity; DNA methylation; DNA repair; DNMT1; non-catalytic activity; pluripotency

Funding

  1. Department of Biotechnology, Department of Science and Technology and Scientific Engineering Research Board
  2. Indian Council of Medical Research
  3. BITS Pilani

Ask authors/readers for more resources

DNMT1 is a key enzyme responsible for methylating the daughter strand in newly replicated DNA. Apart from its role in gene repression through methylation, recent data suggest that DNMT1 can also modulate gene expression independent of its catalytic activity and participate in various processes such as the cell cycle, DNA damage repair, and stem cell function.
DNMT1 is the main enzyme that uses the information on DNA methylation patterns in the parent strand and methylates the daughter strand in freshly replicated hemimethylated DNA. It is widely known that DNMT1 is a component of the epigenetic machinery mediating gene repression via increased promoter methylation. However, recent data suggest that DNMT1 can also modulate gene expression independent of its catalytic activity and participates in multiple processes including the cell cycle, DNA damage repair and stem cell function. This review summarizes the noncanonical functions of DNMT1, some of which are clearly independent of maintenance methylation. Finally, phenotypic data on altered DNMT1 levels suggesting that maintenance of optimal levels of DNMT1 is vital for normal development and health is presented.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Phenotypic association of 15q11.2 CNVs of the region of breakpoints 1-2 (BP1-BP2) in a large cohort of samples referred for genetic diagnosis

K. Naga Mohan, Ye Cao, Justin Pham, Sau Wai Cheung, Lori Hoffner, Z. Zishuo Ou, Urvashi Surti, Edwin H. Cook, Arthur L. Beaudet

JOURNAL OF HUMAN GENETICS (2019)

Article Genetics & Heredity

Analysis of 15q11.2 CNVs in an Indian population with schizophrenia

Sonal Saxena, Poornima Kkani, Chellamuthu Ramasubramanian, Srinivasan Ganesh Kumar, Raghav Monisha, Gundugurti Prasad Rao, Kommu Naga Mohan

ANNALS OF HUMAN GENETICS (2019)

Article Multidisciplinary Sciences

CalPen (Calculator of Penetrance), a web-based tool to estimate penetrance in complex genetic disorders

Aditya Addepalli, Sakhare Kalyani, Minali Singh, Debashree Bandyopadhyay, K. Naga Mohan

PLOS ONE (2020)

Article Genetics & Heredity

Dysregulation of schizophrenia-associated genes and genome-wide hypomethylation in neurons overexpressing DNMT1

Sonal Saxena, Sumana Choudhury, Pranay Amruth Maroju, Anuhya Anne, Lov Kumar, Kommu Naga Mohan

Summary: About 50% of dysregulated genes in schizophrenia patients also showed altered transcript levels in neurons with increased DNMT1, independently of DNA methylation. These neurons unexpectedly exhibited genome-wide hypomethylation, along with increased transcript levels of Tet1 and Apobec 1-3 genes, as well as increased activity and copy number of LINE-1 elements. The similarities observed between these neurons and schizophrenia brain samples suggest that DNMT1 overexpression could be a risk factor for schizophrenia.

EPIGENOMICS (2021)

Article Genetics & Heredity

Genome-wide methylation analysis of post-mortem cerebellum samples supports the role of peroxisomes in autism spectrum disorder

Anuhya Anne, Sonal Saxena, Kommu Naga Mohan

Summary: Large DNA methylation changes were found in the gene promoters of cerebellum tissues of patients with autism spectrum disorder (ASD), including genes involved in peroxisome function. This supports the hypothesis that impaired peroxisome function/biogenesis is associated with ASD. Similar approaches could be used to identify rare epimutations in ASD and other complex disorders.

EPIGENOMICS (2022)

Article Cell Biology

Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias.

Anuhya Anne, Lov Kumar, Revanth Kumar K. Salavadi, Pradeep S. S. Anand, Swapna Nuguri, Sukhvinder Bindra, Kanapuram Venkat Ramana Reddy, Gummanur Madhusudhana R. Rao, Kommu Naga N. Mohan

Summary: Oral leukoplakia is a potentially malignant disorder without known genome-scale somatic single nucleotide variant profiles in its hyperplastic/hyperkeratotic stage. Exome sequencing of cases at this stage revealed genetic alterations associated with tobacco chewing, age-related mutation signatures, and dysplasia. Variants in cancer driver genes and those shared with oral dysplasias may contribute to further progression and increased susceptibility to oral cancer.

CYTOGENETIC AND GENOME RESEARCH (2023)

Article Multidisciplinary Sciences

Reproducible differentiation and characterization of neurons from mouse embryonic stem cells

Sonal Saxena, Sumana Choudhury, K. Naga Mohan

METHODSX (2020)

No Data Available